Obesity.
Arterburn
David
D
University of Cincinnati Institute for Health Policy and Health Services Research, and the Cincinnati Department of Veterans Affairs, Cincinnati, USA.
D000328:Adult; D001067:Appetite Depressants / Q000627:therapeutic use; D003503:Cyclobutanes / Q000627:therapeutic use; D004053:Diethylpropion / Q000627:therapeutic use; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D008454:Mazindol / Q000627:therapeutic use; D009765:Obesity / Q000188:drug therapy*; D000077403:Orlistat; D010645:Phentermine / Q000627:therapeutic use; D010665:Phenylpropanolamine / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D001067:Appetite Depressants; D003503:Cyclobutanes; D004053:Diethylpropion; D005473:Fluoxetine; D007783:Lactones; D008454:Mazindol; D000077403:Orlistat; D010645:Phentermine; D010665:Phenylpropanolamine; D017367:Selective Serotonin Reuptake Inhibitors; C058254:sibutramine